Myriad Genetics | MYGN - Sales Revenues

Stock Price
5.09
Daily Change
-0.01 -0.20%
Monthly
-23.23%
Yearly
-58.98%
Q1 Forecast
5.45

Myriad Genetics reported $205.7M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Agilent USD 1.86B 123M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Bio-Rad Laboratories USD 653M 1.4M Sep/2025
Bruker USD 860.5M 63.1M Sep/2025
Danaher USD 6.84B 790M Dec/2025
Exact Sciences USD 851M 39.9M Sep/2025
Hologic USD 1.05B 0 Dec/2025
Illumina USD 1.16B 80M Dec/2025
J&J USD 24.6B 610M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 205.7M 7.4M Sep/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
Quidel USD 700M 86M Sep/2025
Repligen USD 189M 7M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Standard Biotools USD 19.55M 2.21M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Veracyte USD 131.9M 1.74M Sep/2025
Waters USD 800M 29M Sep/2025